Vetr Upgrades Valeant After Price Dips

Loading...
Loading...

The Vetr crowd on Thursday upgraded its rating on Valeant Pharmaceuticals International, Inc. VRX, from 4 stars (Buy), issued two days ago, to 5 stars. Crowd sentiment at the time of the upgrade was largely positive, with 80 percent of Vetr user ratings bullish.

Share price In Valeant is back on the uptrend after dipping below $17 earlier in the week after hitting a four-month high of $17.75. The stock closed Thursday's session up, but still below that high at $17.65

See how crowdsourced ratings could help you time the market.

Currently, the Vetr crowd's average price target on Valeant is up at $22.46, which is still below the average analyst price target of $24.58. Valeant Pharmaceuticals is a popular stock on Vetr as more than 2 percent of users are holding VRX in their watch-lists.

Posted In: UpgradesPrice TargetCrowdsourcingAnalyst RatingsGeneralVetr
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...